Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS

Background: The high heterogeneity of acute respiratory distress syndrome (ARDS) contributes to paradoxical conclusions from previous investigations of rosuvastatin for ARDS. Identification of the population (phenotype) that could benefit from rosuvastatin is a novel exploration for the precise trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shi, Lu, Zhonghua, Wu, Zongsheng, Xie, Jianfeng, Yang, Yi, Qiu, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737567/
https://www.ncbi.nlm.nih.gov/pubmed/33335905
http://dx.doi.org/10.3389/fmed.2020.598621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737567/
https://www.ncbi.nlm.nih.gov/pubmed/33335905
http://dx.doi.org/10.3389/fmed.2020.598621

Ejemplares similares